A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet T...

por Angiolillo, Dominick J., Badimon, Juan Jose, Saucedo, Jorge F., Frelinger, Andrew L., Michelson, Alan D., Jakubowski, Joseph A., Zhu, Baojin, Ojeh, Clement K., Baker, Brian A., Effron, Mark B.
Publicado 2011

Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inh...

por Jackson, Larry R., Peterson, Eric D., McCoy, Lisa A., Ju, Christine, Zettler, Marjorie, Baker, Brian A., Messenger, John C., Faries, Douglas E., Effron, Mark B., Cohen, David J., Wang, Tracy Y.
Publicado 2016

How Reliable are Patient‐Reported Rehospitalizations? Implications for the Design of Future Practical Clinical Studies

por Krishnamoorthy, Arun, Peterson, Eric D., Knight, J. David, Anstrom, Kevin J., Effron, Mark B., Zettler, Marjorie E., Davidson‐Ray, Linda, Baker, Brian A., McCollam, Patrick L., Mark, Daniel B., Wang, Tracy Y.
Publicado 2016

Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From th...

por Vora, Amit N., Peterson, Eric D., McCoy, Lisa A., Effron, Mark B., Anstrom, Kevin J., Faries, Douglas E., Zettler, Marjorie E., Fonarow, Gregg C., Baker, Brian A., Stone, Gregg W., Wang, Tracy Y.
Publicado 2016